About

Adamas Biotech develops science-driven nutraceutical products based on the therapeutic potential of green tea extracts.

Its proprietary extract, Theaphenon E®, is derived from Camellia sinensis leaves sourced exclusively from the spring harvest, when bioactive compounds are naturally more concentrated. The extract features a high-purity profile – 90% green tea catechins and 65% EGCG – and is produced under rigorous quality-control standards covering contaminant testing, microbiological purity and sustainable sourcing.

Leveraging its antioxidant, anti-inflammatory and analgesic properties, Adamas Biotech targets applications in urological health, gastrointestinal conditions including IBS, and cardiovascular wellbeing.

Adamas Biotech

Area

Founded

2018